Similarly, Zhang et al. [3] reported that the average levels of sPD-L1 in patients with advanced NSCLC and healthy controls were significantly different (0.723±0.081 vs 0.565±0.048 ng/mL, respectively, p < 0.001). Here, SPDL1 is linked to non-small cell lung carcinoma.